QCM
AZN icon

Quantinno Capital Management’s AstraZeneca AZN Stock Holding History

Quantinno Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Buy
+9,000
New +$1.74M ﹤0.01% 1696
2025
Q3 		– Sell
-10,000
Closed -$1.4M – 2932
2025
Q2 		$1.4M Buy
+10,000
New +$1.4M 0.01% 1199

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Quantinno Capital Management's AZN Position: Q1 2026 in Review

Quantinno Capital Management increased its AstraZeneca (AZN) stake by 25% in Q1 2026, buying an estimated $8.97M and bringing the position to 235,094 shares worth $46.2M. The position accounts for 0.08% of the portfolio, ranked #297.

Quantinno Capital Management first reported a position in AZN in Q2 2022 and has held it in 15 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Quantinno Capital Management held 235,094 shares of AstraZeneca worth $46.2M as of Q1 2026.
  • Quantinno Capital Management bought 46,537 AstraZeneca shares in Q1 2026, an estimated $8.97M.
  • AstraZeneca made up 0.08% of Quantinno Capital Management's portfolio in Q1 2026, its #297 holding.
  • Quantinno Capital Management first reported a position in AstraZeneca in Q2 2022 and has held it in 15 quarters since.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.